Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil versus azathioprine for induction of remission in treatment-naive autoimmune hepatitis
2016-001038-91Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in autoimmune hepatitis (AIH) comparing Mycophenolate mofetil + prednisolone with Azathioprine + prednisolone (2 arms). Primary endpoint: Biochemical remission at 24 weeks. Started Oct 2016; status: active.
02
Drugs
mycophenolate mofetilazathioprine
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on 2016-001038-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001038-91.